Search Results - "Shapiro, JD"

A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy by Lim, L, Gibbs, P, Yip, D, Shapiro, J D, Dowling, R, Smith, D, Little, A, Bailey, W, Liechtenstein, M

“…To prospectively evaluate the efficacy and safety of Selective Internal Radiation (SIR) spheres in patients with inoperable liver metastases from colorectal…”
Get full text

Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer by Jalali, A, Gard, G, Banks, S, Dunn, C, Wong, HL, Wong, R, Lee, M, Gately, L, Loft, M, Shapiro, JD, Kosmider, S, Tie, J, Ananda, S, Yeung, J M, Jennens, R, Lee, B, McKendrick, J, Lim, L, Khattak, A, Gibbs, P

“…For patients with refractory metastatic colorectal cancer (mCRC) treatment with Trifluridine/Tipiracil, also known as TAS-102, improves overall survival. This…”
Get full text

Ethical Issues in Contemporary Clinical Genetics by Braverman, Genna, Shapiro, Zachary E., Bernstein, Jonathan A.

“…As genetic sequencing capabilities become more powerful and costs decline, the reach of genomics is expanding beyond research laboratories to the wards,…”
Get full text

Activity of Gemcitabine in Patients with Advanced Ovarian Cancer: Responses Seen Following Platinum and Paclitaxel by Shapiro, Jeremy D., Millward, Michael J., Rischin, Danny, Michael, Michael, Walcher, Vicki, Francis, Prudence A., Toner, Guy C.

“…Thirty-eight women with epithelial ovarian cancer were treated with gemcitabine, a new antimetabolite. All had previously received platinum, and 27 had also…”
Get full text

Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies by Lim, L., Gibbs, P., Yip, D., Shapiro, J. D., Dowling, R., Smith, D., Little, A., Bailey, W., Liechtenstein, M.

“…Aim:  To prospectively evaluate the efficacy and safety of Selective Internal Radiation (SIR) Spheres (Sirtex Medical, Sydney, NSW, Australia) in patients with…”
Get full text

Phase I and Pharmacologic Study of Irinotecan Administered as a 96-Hour Infusion Weekly to Adult Cancer Patients by TAKIMOTO, C. H, MORRISON, G, ISMAIL, A. S, FLEMMING, D, GOSKY, D. M, HIROTA, H, BERGER, S. J, BERGER, N. A, CHEN, A. P, SHAPIRO, J. D, ARBUCK, S. G, WRIGHT, J, HAROLD, N, HAMILTON, J. M, ALLEGRA, C. J, GREM, J. L, QUINN, M, MONAHAN, B. P, BAND, R. A, COTTRELL, J, GUEMEI, A, LLORENS, V, HEHMAN, H

“…We conducted a phase I and pharmacologic study of a weekly 96-hour infusion of irinotecan to determine the maximum-tolerated dose, define the toxicity profile,…”
Get full text

Nurses' and Consumers' Understanding of and Comfort With the Patient Self-determination Act by Shapiro, Jane D., Bowles, Kathleen

“…The Patient Self-determination Act became effective in 1991, raising legal, moral, and ethical issues in healthcare. This article outlines the current…”
Get full text

Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparison by Toner, G C, Shapiro, J D, Laidlaw, C R, Rischin, D, Millward, M J, Wolf, M, Januszewicz, H, Mitchell, S V, Curran, A C, Matthews, J P, Bishop, J F

“…Granulocyte colony-stimulating factor (G-CSF) administered prophylactically after chemotherapy reduces the duration and severity of neutropenia. This…”
Get more information

Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer by Shapiro, Jeremy D., Rothenberg, Mace L., Sarosy, Gisele A., Steinberg, Seth M., Adamo, Debra O., Reed, Eddie, Ozols, Robert F., Kohn, Elise C.

“…BACKGROUND The authors combined cisplatin and carboplatin together with cyclophosphamide to maximize platinum dose intensity in patients with advanced…”
Get full text

A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma by Shapiro, J D, Harold, N, Takimoto, C, Hamilton, J M, Vaughn, D, Chen, A, Steinberg, S M, Liewehr, D, Allegra, C, Monahan, B, Lash, A, Grollman, F, Flemming, D, Behan, K, Johnston, P G, Haller, D, Quinn, M, Morrison, G, Grem, J L

“…We reported previously that the addition of recombinant Escherichia coli human granulocyte-macrophage colony stimulating factor (GM-CSF) to a 5-fluorouracil…”
Get full text

Augmented external fixation of unstable distal radius fractures by Seitz, Jr, W H, Froimson, A I, Leb, R, Shapiro, J D

“…The technique of "augmentation" of external fixation employs the use of percutaneous Kirschner wires to secure the radial styloid fragment as a lateral…”
Get more information

The biomechanical effects of geometric configuration of bone-tendon-bone autografts in anterior cruciate ligament reconstruction by Shapiro, J D, Cohn, B T, Jackson, D W, Postak, P D, Parker, R D, Greenwald, A S

“…This study provides biomechanical support for a new technique of autograft anterior cruciate ligament reconstruction featuring circular bone plugs and…”
Get more information

More pharmaceutical company influence? by SHAPIRO, J. D., PHILLIPS, K‐A., TANNOCK, I. F.

Get full text

Intubating by sense, not dollars by Shapiro, J D

Get full text

Activity and toxicity of docetaxel (Taxotere®) in women with previously treated metastatic breast cancer by Shapiro, J. D., Millward, M. J., Rischin, D., Davison, J. D., Michael, M., Francis, P. A., Ganju, V., Toner, G. C.

“…Background: Metastatic breast cancer is a major cause of cancer death in Australian women. Docetaxel is a new cytotoxic drug that has shown promise in the…”
Get full text

N2O has no place during oropharyngeal and laryngotracheal procedures by Shapiro, J D, el-Baz, N M

Get full text

Angiomyoma in the hand by Shapiro, J D, Froimson, A I

“…Angiomyoma of the upper extremities is not commonly encountered by the orthopedic surgeon. A case of a vascular leiomyoma developing in a 79-year-old woman is…”
Get more information